• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症认知成分的同时效度:阳性和阴性症状量表(PANSS)得分与神经心理学评估的关系

Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.

作者信息

Bell M D, Lysaker P H, Milstein R M, Beam-Goulet J L

机构信息

Psychology Service, Veterans Administration Medical Center, West Haven, CT 06516, USA.

出版信息

Psychiatry Res. 1994 Oct;54(1):51-8. doi: 10.1016/0165-1781(94)90064-7.

DOI:10.1016/0165-1781(94)90064-7
PMID:7701028
Abstract

Cognitive symptoms of schizophrenia may represent a separate component of the disorder that is distinct from positive or negative syndromes. In a previous study, we reported a factor analysis of the Positive and Negative Syndrome Scale (PANSS) that revealed five components, one of which we labeled the Cognitive component. In the present study, we explored the validity of the PANSS Cognitive component by examining correlations between neuropsychological measures and the five factor-analytically derived PANSS scores for 147 subjects with diagnoses of schizophrenia or schizoaffective disorder. Higher scores on the PANSS Cognitive component were significantly correlated with poorer performance on all neuropsychological tests, including the Wisconsin Card Sorting Test (WCST), the Digit Symbol Substitution Task, the Slosson Intelligence Test, and the Gorham Proverbs Test. Multiple regression revealed that these test scores explained 37% of the variance in the Cognitive component score. Neuropsychological tests have very limited associations with the other PANSS components. These results suggest that the Cognitive component of the PANSS is a valid measure of cognitive deficits in schizophrenia, and they support the hypothesis that Cognitive impairment is a distinctive feature of schizophrenia independent of positive and negative syndromes.

摘要

精神分裂症的认知症状可能代表该疾病的一个独立组成部分,有别于阳性或阴性症状。在之前的一项研究中,我们报告了对阳性和阴性症状量表(PANSS)的因子分析,该分析揭示了五个组成部分,其中一个我们标记为认知成分。在本研究中,我们通过检查神经心理学测量与147名被诊断为精神分裂症或分裂情感性障碍的受试者的五个经因子分析得出的PANSS分数之间的相关性,探讨了PANSS认知成分的有效性。PANSS认知成分得分越高,与所有神经心理学测试的较差表现显著相关,包括威斯康星卡片分类测试(WCST)、数字符号替换任务、斯洛森智力测试和戈尔曼谚语测试。多元回归显示,这些测试分数解释了认知成分得分中37%的方差。神经心理学测试与其他PANSS成分的关联非常有限。这些结果表明,PANSS的认知成分是精神分裂症认知缺陷的有效测量指标,并且支持了认知障碍是精神分裂症独立于阳性和阴性症状的一个显著特征这一假设。

相似文献

1
Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.精神分裂症认知成分的同时效度:阳性和阴性症状量表(PANSS)得分与神经心理学评估的关系
Psychiatry Res. 1994 Oct;54(1):51-8. doi: 10.1016/0165-1781(94)90064-7.
2
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
3
Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.精神分裂症中阳性和阴性症状与神经心理学缺陷之间的差异关系。
Schizophr Res. 1997 May 3;25(1):1-10. doi: 10.1016/S0920-9964(96)00098-9.
4
Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).阳性和阴性症状量表(PANSS)三个认知成分的内部一致性、时间稳定性及神经心理学相关性
Schizophr Res. 1999 Jul 27;38(1):27-35. doi: 10.1016/s0920-9964(99)00004-3.
5
Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale.精神分裂症患者神经软体征的临床意义:神经评估量表的因子分析。
Schizophr Res. 2010 Dec;124(1-3):1-12. doi: 10.1016/j.schres.2010.08.036. Epub 2010 Sep 19.
6
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.未使用过抗精神病药物的首发精神病患者的神经心理测试表现与阳性和阴性症状量表(PANSS)之间的关系。
Schizophr Res. 2004 May 1;68(1):11-9. doi: 10.1016/j.schres.2003.07.001.
7
Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia.精神分裂症认知与正性和负性症状量表五因素模型。
Schizophr Res. 2013 Jan;143(1):77-83. doi: 10.1016/j.schres.2012.10.020. Epub 2012 Nov 30.
8
Affect recognition in schizophrenia: a function of global impairment or a specific cognitive deficit.
Psychiatry Res. 1997 Jul 4;71(2):105-13. doi: 10.1016/s0165-1781(97)00050-4.
9
Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.将认知功能与症状领域和埃及精神分裂症患者的洞察力相关联。
Int J Soc Psychiatry. 2020 May;66(3):240-248. doi: 10.1177/0020764019897697. Epub 2020 Jan 13.
10
Karolinska Scales of Personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls.精神分裂症患者和健康对照者的卡罗林斯卡人格、认知及精神病性症状量表
Nord J Psychiatry. 2016;70(1):53-61. doi: 10.3109/08039488.2015.1048720. Epub 2015 Jun 18.

引用本文的文献

1
A correlation study on EEG signals during visual concentration test and clinical evaluation in schizophrenia patients.精神分裂症患者视觉注意力测试期间脑电图信号与临床评估的相关性研究。
BMC Psychiatry. 2025 Aug 5;25(1):761. doi: 10.1186/s12888-025-07237-w.
2
Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia.精神分裂症中嗓音特征、精神症状与认知功能的关联
Neuropsychiatr Dis Treat. 2025 Apr 23;21:943-954. doi: 10.2147/NDT.S514927. eCollection 2025.
3
Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.
精神分裂症谱系中的认知障碍:探索一般智力因素与社会人口统计学、精神病理学、神经发育及遗传学之间的关系。
Psychol Med. 2024 Dec 2;54(15):1-12. doi: 10.1017/S0033291724002538.
4
Cognitive Impairments Related to COMT and Neuregulin 1 Phenotypes as Transdiagnostic Markers in Schizophrenia Spectrum Patients.与儿茶酚-O-甲基转移酶(COMT)和神经调节蛋白1(Neuregulin 1)表型相关的认知障碍作为精神分裂症谱系患者的跨诊断标志物
J Clin Med. 2024 Oct 25;13(21):6405. doi: 10.3390/jcm13216405.
5
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia.精神分裂症中与疾病相关的变量及静息态脑活动异常
Front Psychiatry. 2024 Aug 6;15:1458624. doi: 10.3389/fpsyt.2024.1458624. eCollection 2024.
6
High-Density Lipoprotein Correlates with Cognitive Functioning in Schizophrenic Women.高密度脂蛋白与精神分裂症女性的认知功能相关。
Brain Sci. 2024 Jul 12;14(7):699. doi: 10.3390/brainsci14070699.
7
Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.解析精神分裂症和自闭症谱系障碍中的阴性和阳性症状。
Schizophr Res. 2024 Sep;271:1-8. doi: 10.1016/j.schres.2024.07.002. Epub 2024 Jul 14.
8
Predictors of Motivation to Receive a COVID-19 Vaccination and the Number of COVID-19 Vaccine Doses Received in Patients with Schizophrenia.精神分裂症患者接种新冠疫苗的动机预测因素及新冠疫苗接种剂量数
Vaccines (Basel). 2023 Nov 29;11(12):1781. doi: 10.3390/vaccines11121781.
9
Optimized adaptive neuro-fuzzy inference system based on hybrid grey wolf-bat algorithm for schizophrenia recognition from EEG signals.基于混合灰狼-蝙蝠算法的优化自适应神经模糊推理系统用于从脑电图信号中识别精神分裂症
Cogn Neurodyn. 2023 Feb;17(1):133-151. doi: 10.1007/s11571-022-09817-y. Epub 2022 May 28.
10
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.精神分裂症认知障碍:病因、发病机制与治疗。
Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23.